Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 120.56% | -20.48% | 864.24% | 31.73% | -25.64% |
| Total Depreciation and Amortization | -15.53% | 12.98% | -3.90% | -3.60% | 6.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.73% | -22.04% | -150.73% | -48.93% | -32.61% |
| Change in Net Operating Assets | -193.49% | 60.18% | 67.39% | 958.06% | -38.16% |
| Cash from Operations | 109.48% | 21.33% | 109.41% | 52,060.00% | -143.52% |
| Capital Expenditure | 30.70% | -338.68% | -290.57% | 76.27% | 85.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2,356.28% | -333.29% | -290.57% | -25,013.33% | 85.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -55.67% | -91.21% | -98.09% | -97.43% | -6.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.36% | -923.65% | -98.09% | -107.07% | 6,350.76% |
| Foreign Exchange rate Adjustments | 1,153.25% | -220.86% | 251.48% | -104.69% | -135.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.59% | -5,325.66% | 169.97% | -2,507.37% | 2,353.29% |